Purpose: To compare tumor control, vision, and complications between patients with a choroidal melanoma of Design: Retrospective, comparative case series. Participants: One hundred sixty-four consecutive patients with a choroidal melanoma of Methods: Diagnosis was based on growth or high-risk characteristics. The apical dose was 100 to 120 Gy aiming to deliver >= 250 Gy to the sclera. Plaque positioning was modeled retrospectively. An increase of >= 0.3 mm in thickness and >= 0.5 mm in LBD indicated local recurrence. Outcomes were compared with cumulative incidence analysis and Cox regression. Median follow-up time for patients still alive was 8.4 years. Main Outcome Measures: Recurrence rate, low vision, blindness, radiation maculopathy, a...
Purpose: To illustrate an approach to evidence-based medical practice by reporting the Collaborativ...
BACKGROUND/AIMS: To evaluate the clinical features and prognosis of choroidal melanoma in Korean pa...
Purpose: To report the results of a patient’s tailored therapeutic approach using a second course of...
Purpose: To compare tumor control, vision, and complications between patients with a choroidal melan...
PURPOSE: The purpose of this study was to report clinical outcomes of ruthenium-106 ((106)Ru) brachy...
PURPOSE: To evaluate low- vs high-dose plaque brachytherapy for juxtapapillary choroidal melanoma. D...
PURPOSE: The purpose of this study is to report on treatment outcomes for medium-sized choroidal mel...
PURPOSE: To evaluate long-term outcomes of eye-conserving treatment using Ruthenium-106 plaque brach...
Purpose: To evaluate the outcomes of ruthenium-106 (106Ru) brachytherapy in terms of radiation param...
Purpose: To evaluate the impact on dose distribution to eye organs-at-risk (eOARs) of a computed tom...
Purpose: To study the feasibility of using Cherenkov luminescence imaging (CLI) to evaluate and docu...
Uveal melanomas constitute melanomas arising from the choroid, the ciliary body or the iris, and in ...
Abstract AIM: To evaluate our community-based institutional experience of the treatment of uveal mel...
PURPOSE: To evaluate long-term outcomes of eye-conserving treatment using Ruthenium-106 plaque brach...
Purpose: To investigate how treatment complications are related to dosimetric parameters after ruthe...
Purpose: To illustrate an approach to evidence-based medical practice by reporting the Collaborativ...
BACKGROUND/AIMS: To evaluate the clinical features and prognosis of choroidal melanoma in Korean pa...
Purpose: To report the results of a patient’s tailored therapeutic approach using a second course of...
Purpose: To compare tumor control, vision, and complications between patients with a choroidal melan...
PURPOSE: The purpose of this study was to report clinical outcomes of ruthenium-106 ((106)Ru) brachy...
PURPOSE: To evaluate low- vs high-dose plaque brachytherapy for juxtapapillary choroidal melanoma. D...
PURPOSE: The purpose of this study is to report on treatment outcomes for medium-sized choroidal mel...
PURPOSE: To evaluate long-term outcomes of eye-conserving treatment using Ruthenium-106 plaque brach...
Purpose: To evaluate the outcomes of ruthenium-106 (106Ru) brachytherapy in terms of radiation param...
Purpose: To evaluate the impact on dose distribution to eye organs-at-risk (eOARs) of a computed tom...
Purpose: To study the feasibility of using Cherenkov luminescence imaging (CLI) to evaluate and docu...
Uveal melanomas constitute melanomas arising from the choroid, the ciliary body or the iris, and in ...
Abstract AIM: To evaluate our community-based institutional experience of the treatment of uveal mel...
PURPOSE: To evaluate long-term outcomes of eye-conserving treatment using Ruthenium-106 plaque brach...
Purpose: To investigate how treatment complications are related to dosimetric parameters after ruthe...
Purpose: To illustrate an approach to evidence-based medical practice by reporting the Collaborativ...
BACKGROUND/AIMS: To evaluate the clinical features and prognosis of choroidal melanoma in Korean pa...
Purpose: To report the results of a patient’s tailored therapeutic approach using a second course of...